These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The effect of HDL mimetic peptide 4F on PON1. Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879 [TBL] [Abstract][Full Text] [Related]
11. The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. Sparks DL; Lund-Katz S; Phillips MC J Biol Chem; 1992 Dec; 267(36):25839-47. PubMed ID: 1464598 [TBL] [Abstract][Full Text] [Related]
12. Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity. Oda MN; Bielicki JK; Berger T; Forte TM Biochemistry; 2001 Feb; 40(6):1710-8. PubMed ID: 11327831 [TBL] [Abstract][Full Text] [Related]
13. Effect of leucine to phenylalanine substitution on the nonpolar face of a class A amphipathic helical peptide on its interaction with lipid: high resolution solution NMR studies of 4F-dimyristoylphosphatidylcholine discoidal complex. Mishra VK; Palgunachari MN; Krishna R; Glushka J; Segrest JP; Anantharamaiah GM J Biol Chem; 2008 Dec; 283(49):34393-402. PubMed ID: 18845546 [TBL] [Abstract][Full Text] [Related]
15. Human carotid plaque phosphatidylcholine specifically interacts with paraoxonase 1, increases its activity, and enhances its uptake by macrophage at the expense of its binding to HDL. Cohen E; Aviram M; Khatib S; Artoul F; Rabin A; Mannheim D; Karmeli R; Salamon T; Vaya J Free Radic Biol Med; 2014 Nov; 76():14-24. PubMed ID: 25091896 [TBL] [Abstract][Full Text] [Related]
16. Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies. Efrat M; Rosenblat M; Mahmood S; Vaya J; Aviram M Atherosclerosis; 2009 Feb; 202(2):461-9. PubMed ID: 18585720 [TBL] [Abstract][Full Text] [Related]
17. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease. Göçmen AY; Gümüşlü S; Semiz E Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047 [TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation, intestine, and paraoxonase-1. Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995 [TBL] [Abstract][Full Text] [Related]
19. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity. Sorenson RC; Bisgaier CL; Aviram M; Hsu C; Billecke S; La Du BN Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2214-25. PubMed ID: 10479665 [TBL] [Abstract][Full Text] [Related]
20. The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function. James RW; Deakin SP Adv Exp Med Biol; 2010; 660():173-81. PubMed ID: 20221880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]